// App-Quantinova.ai

PB0348 : Small-molecule cyclophilin inhibitors as a potential therapeutic application to limit thrombosis

Researchers

Presenter

  • J. Van Bael

Principal Investigators

  • A. Vandenbulcke

  • S. De Meyer

  • K. Vanhoorelbeke

  • C. Tersteeg

Medical Centers

  • Laboratory for Thrombosis Research, KU Leuven campus Kulak Kortrijk, Kortrijk, West-Vlaanderen, Belgium

  • Laboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium, Kortrijk, West-Vlaanderen, Belgium

  • INSERM U955, Team Viruses, Hepatology Cancer, Créteil, Ile-de-France, France

  • Centre de Biologie Structurale (CBS), INSERM U1054, CNRS UMR5048, Université de Montpellier, Montpellier, Languedoc-Roussillon, France

  • INSERM U955, Team Viruses, Hepatology Cancer & National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Hôpital Henri Mondor, Université Paris-Est, Créteil, Ile-de-France, France

  • Laboratory for Thrombosis Research, KU Leuven Campus Kulak, Kortrijk, Belgium, Kortrijk, West-Vlaanderen, Belgium

Locations

  • Belgium

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • cyclosporin A

  • cyclosporin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved